UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): October 19, 2017

 

MEDICAL INNOVATION HOLDINGS, INC.

(Exact name of registrant as specified in its charter)

 

Colorado   000-27211   84-1469319
(State or Other Jurisdiction   (Commission   (I.R.S. Employer
of Incorporation)   File Number)   Identification No.)

 

5805 State Bridge Road, Suite G-328, Duluth, Georgia 30097

(Address of Principal Executive Offices) (Zip Code)

 

(866) 883-3793

(Registrant’s telephone number, including area code)

 

 

 

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

[  ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
[  ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
[  ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
[  ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

 
   

 

SECTION 7 — REGULATION FD DISCLOSURE

 

Item 7.01 Regulation FD Disclosure .

 

Press Release

 

The information in this Item 7.01 of this Current Report is furnished pursuant to Item 7.01 and shall not be deemed “filed” for any purpose, including for the purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that Section. The information in this Current Report on Form 8-K shall not be deemed incorporated by reference into any filing under the Securities Act or the Exchange Act regardless of any general incorporation language in such filing.

 

On October 19, 2017 Medical Innovation Holdings Inc. issued a press release.

 

The text of the press release in its entirety is attached herewith as Exhibit 99.1.

 

SECTION 9 — FINANCIAL STATEMENTS AND EXHIBITS

 

Item 9.01 Financial Statements and Exhibits.

 

The following is a complete list of exhibits filed as part of this Report.

 

Exhibit numbers correspond to the numbers in the exhibit table of Item 601 of Regulation S-K.

 

Exhibit No.   Description
99.1   Press Release

 

 
   

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

 

  Medical Innovation Holdings, Inc.
     
  By /s/ Arturo Jake Sanchez
  Name:

Arturo “Jake” Sanchez

  Title: CEO

 

Date: October 20, 2017

 

 
   

 

 

 

News Release

 

Medical Innovation Holdings, Inc. (MIHI) Announces Manufacturing Supply Agreement for NextGen Telemedicine Equipment and Peripherals

 

DULUTH, GEORGIA (October 19, 2017) Medical Innovation Holdings Inc. (OTC Pink: MIHI) today announces its manufacturing agreement with MDI Source, a Georgia-based company serving the technology industry for over 30 years. Per the agreement, MDI will manufacture customized telemedicine equipment to fit the footprint of any doctor’s office that signs up to utilize MIHI’s telemedicine practice. This arrangement will allow MIHI to offer these offices a variety of telemedicine equipment that supports the shift toward a blend of in-office and virtual visits.

 

Coupling MDI’s hardware with MIHI’s EMR/PMS software solution provides rural clinics a comprehensive solution unmatched in the marketplace. Additionally, MDI will provide various levels of technical support and services to MIHI clients, ensuring world-class service with world-class products.

 

“When we entered this marketplace, the cost for telemedicine workstations was significantly high,” says MIHI CEO Jake Sanchez. “This agreement with MDI is a game changer for MIHI and the marketplace, as we can now offer feature rich and user friendly comprehensive EMP/PMS software solutions at half the price. Our business plan is to subsidize a significant portion of the cost, if not 100%, of the telemedicine stations for our rural primary clinics that sign up and register to utilize our network of specialists. We want to make it as easy as possible for the rural clinics to join up with us.”

 

About Medical Innovation Holdings, Inc.

 

Medical Innovation Holdings, Inc. (MIHI) owns and operates strategically aligned health care service companies focused on the delivery of clinical virtual medicine (health) to bring quality medical care to all areas of need, including rural and underdeveloped areas across the country. Through its wholly owned 3Point Care subsidiary, MIHI provides personalized high-tech telemedicine encounters pairing the company’s virtual health specialty doctors and traditional primary doctors that utilize next-gen virtual health technologies to connect a patient with a multi-disciplinary specialty clinical health care practice. Through its other companies and partnerships, MIHI offers Affordable Care Organization (ACO) support, wellness and prevention, lab analysis and lab services, and remote diagnostic monitoring.

 

MIHI serves a number of constituents and stakeholders interested in reducing the cost of care, enhancing the quality of care, promoting access to care, and maintaining the continuum of care.

 

For more information, visit http://www.MedicalInnovationHoldings.com.

 

 
   

 

FORWARD-LOOKING STATEMENTS

 

This press release contains forward-looking statements as defined within Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements relate to future events, including our ability to raise capital, or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

 

For a discussion of these risks and uncertainties, please see our filings with the Securities and Exchange Commission. Our public filings with the SEC are available from commercial document retrieval services and at the website maintained by the SEC at http://www.sec.gov.

 

Investor Contacts:

Medical Innovation Holdings

866-883-3793 Office

Investor@MedicalInnovationHoldings.com

 

Communications Contact:

Network News Wire (NNW)

New York, New York

www.NetworkNewsWire.com

212.418.1217 Office

Editor@NetworkNewsWire.com